Mitsubishi Gas Chemical Company (4182) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Feb, 2026Executive summary
Net sales for FY2024 1H decreased 2.9% year-over-year to ¥388.1 billion, mainly due to the transition of JSP Corporation to an equity-method affiliate, despite higher methanol prices and yen depreciation.
Operating profit rose 52.7% year-over-year to ¥33.7 billion, driven by strong performance in the Specialty Chemicals segment.
Ordinary profit increased 50.1% to ¥37.4 billion, supported by higher operating profit and improved equity in earnings of affiliates.
Interim profit attributable to owners of parent fell 20.8% to ¥24.7 billion, reflecting the absence of a prior-year gain from step acquisitions.
Financial highlights
FY2024 1H EPS was ¥123.47, down from ¥152.67 in the prior year.
Gross profit for the period was ¥89.4 billion, up from ¥86.4 billion in the previous year.
Comprehensive income dropped 48.5% year-over-year to ¥29.99 billion.
Free cash flow turned negative at -¥14.0 billion, compared to ¥17.6 billion in the prior year, due to higher investing cash outflows.
Total assets increased to ¥1,087.5 billion as of September 30, 2024.
Outlook and guidance
Full-year FY2024 net sales forecast revised down to ¥770.0 billion, but operating profit and ordinary profit forecasts raised to ¥56.0 billion and ¥63.0 billion, respectively.
EPS for the full year is projected at ¥243.10.
Annual dividend forecast revised upward to ¥95.00 per share.
Share repurchases of up to ¥15 billion (5.6 million shares) and cancellation of repurchased shares announced.
Latest events from Mitsubishi Gas Chemical Company
- Operating profit more than doubled on strong specialty chemicals demand and yen depreciation.4182
Q1 202516 Feb 2026 - Operating profit rose 17.2% despite lower sales, driven by Specialty Chemicals and yen effects.4182
Q3 202516 Feb 2026 - Operating profit up 7.4% despite 4.9% sales drop; FY2025 outlook cautious.4182
Q4 202516 Feb 2026 - Profits fell on weak chemical markets and FX volatility, but sales forecast was raised.4182
Q1 202616 Feb 2026 - Profits fell on lower prices and impairments, but dividend forecast raised to ¥100 per share.4182
Q3 202616 Feb 2026 - Impairment loss and weak markets drive lower profits and a revised net loss outlook for FY2025.4182
Q2 202616 Feb 2026